WHO launches first biosimilar medicine to treat Breast Cancer

News:The World Health Organization(WHO) has launched its first biosimilar medicine to treat breast cancer named Trastuzumab. Facts: About Trastuzumab: Trastuzumab drug was included in the WHO Essential Medicines List in 2015 as an essential treatment for about 20% of breast cancers.  It has shown high efficacy in curing early stage breast cancer and in some… Continue reading WHO launches first biosimilar medicine to treat Breast Cancer